Physician profile
Robert C Polite
NPI 1386698611
$1,234.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $68.07 · 2021: $124 · 2022: $96.57 · 2023: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $279.96 | 2019-2023 | Epclusa |
| Mdd US Operations, LLC | $220.64 | 2019-2020 | |
| Allergan, INC. | $185.73 | 2019-2020 | |
| Indivior INC. | $167.26 | 2019 | |
| Abbvie INC. | $81.01 | 2019-2022 | |
| Alkermes, INC. | $64.92 | 2019-2023 | Vivitrol |
| Orexo US, INC. | $46.14 | 2019-2022 | |
| Uswm, LLC | $46.00 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.64 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $32.80 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $30.18 | 2019 | |
| Novo Nordisk INC | $20.80 | 2019 | |
| Kaleo, INC. | $15.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Polite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.